Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nucleoside Analogue in Late Preganancy to Prevent Vertical Transmission of Hepatitis B Virus

NCT01788371 is registered in ClinicalTrials.gov with Hua Zhang as lead sponsor.

NCT NCT01788371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01788371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nucleoside Analogue in Late Preganancy to Prevent Vertical Transmission of Hepatitis B Virus
Lead sponsor
Hua Zhang
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
July 31, 2013
Enrollment
700 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic infection, hepatitis b infection, viremia